In addition, the small-molecule-specific VEGFR3 tyrosine kinase inhibitor SAR131675 significantly reduced the growth of the primary tumor, lung metastases and macrophage infiltration in a mouse model of breast carcinoma [77]. Here, FLT4 is linked to breast carcinoma.